Correlation Between Viracta Therapeutics and Chromadex Corp
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Chromadex Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Chromadex Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Chromadex Corp, you can compare the effects of market volatilities on Viracta Therapeutics and Chromadex Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Chromadex Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Chromadex Corp.
Diversification Opportunities for Viracta Therapeutics and Chromadex Corp
-0.91 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Viracta and Chromadex is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Chromadex Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chromadex Corp and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Chromadex Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chromadex Corp has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Chromadex Corp go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Chromadex Corp
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Chromadex Corp. But the stock apears to be less risky and, when comparing its historical volatility, Viracta Therapeutics is 3.31 times less risky than Chromadex Corp. The stock trades about -0.47 of its potential returns per unit of risk. The Chromadex Corp is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest 367.00 in Chromadex Corp on August 29, 2024 and sell it today you would earn a total of 392.00 from holding Chromadex Corp or generate 106.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viracta Therapeutics vs. Chromadex Corp
Performance |
| Timeline |
| Viracta Therapeutics |
| Chromadex Corp |
Viracta Therapeutics and Chromadex Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viracta Therapeutics and Chromadex Corp
The main advantage of trading using opposite Viracta Therapeutics and Chromadex Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Chromadex Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chromadex Corp will offset losses from the drop in Chromadex Corp's long position.| Viracta Therapeutics vs. Eliem Therapeutics | Viracta Therapeutics vs. Scpharmaceuticals | Viracta Therapeutics vs. Milestone Pharmaceuticals | Viracta Therapeutics vs. Seres Therapeutics |
| Chromadex Corp vs. Ikena Oncology | Chromadex Corp vs. Eliem Therapeutics | Chromadex Corp vs. HCW Biologics | Chromadex Corp vs. Exicure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |